Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression

Molecular Therapy - Tập 23 - Trang 769-778 - 2015
Kevin J Curran1, Beatrijs A Seinstra2, Yan Nikhamin2, Raymond Yeh2, Yelena Usachenko2, Dayenne G van Leeuwen2, Terence Purdon3, Hollie J Pegram2, Renier J Brentjens2
1Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Tài liệu tham khảo